Compounds > thymopentin
Page last updated: 2024-08-23

thymopentin and HIV Coinfection

thymopentin has been researched along with HIV Coinfection in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertollo, L; Biselli, R; D'Amelio, R; D'Offizi, G; Fagiolo, U; Ferrara, R; Nisini, R; Paganelli, R1
Beall, G; Blick, G; Calabrese, LH; Conant, MA; Fisher, A; Galpin, JE; Goldstein, G; Grossman, HA; Hirsch, RL; Stampone, P1
Diez, RA; Estévez, ME; Iannitelli, PS; Palacios, MF; Sen, L1
Fisher, AC; Goldstein, G; Hirsch, RL; Merigan, TC; Meyerson, LA; Winters, MA1
Calabrese, LH; Conant, MA; Goldstein, G; Hirsch, RL; Kremer, AB; Meyerson, LA; Poiesz, BJ; Rasheed, S; Thompson, SE; Wang, CC1

Trials

4 trial(s) available for thymopentin and HIV Coinfection

ArticleYear
Humoral response to influenza hemagglutinin: oligoclonal spectrotype and failure of thymopentin as immunoadjuvant.
    Gerontology, 1995, Volume: 41, Issue:1

    Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aging; Antibodies, Viral; Combined Modality Therapy; Enzyme-Linked Immunosorbent Assay; Female; Hemagglutinins, Viral; HIV Infections; Humans; Immunoglobulin G; Influenza A virus; Influenza Vaccines; Isoelectric Focusing; Male; Middle Aged; Thymopentin; Treatment Failure

1995
Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1995, Mar-01, Volume: 8, Issue:3

    Topics: Adult; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; HIV; HIV Core Protein p24; HIV Infections; Humans; Injections, Subcutaneous; Male; Middle Aged; Patient Compliance; Pentamidine; Pneumonia, Pneumocystis; Prognosis; Proportional Hazards Models; Thymopentin; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine

1995
The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin.
    AIDS (London, England), 1996, Volume: 10, Issue:2

    Topics: Adjuvants, Immunologic; Adult; Antigen-Antibody Complex; Antiviral Agents; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Female; HIV Core Protein p24; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Mutation; Predictive Value of Tests; Prognosis; Retrospective Studies; RNA, Viral; Thymopentin; Viral Load; Zidovudine

1996
Maintenance of CD4+ cells by thymopentin in asymptomatic HIV-infected subjects: results of a double-blind, placebo-controlled study.
    AIDS (London, England), 1992, Volume: 6, Issue:11

    Topics: Amino Acid Sequence; CD4-Positive T-Lymphocytes; Double-Blind Method; HIV Infections; Humans; Leukocyte Count; Molecular Sequence Data; Safety; Thymopentin; Time Factors

1992

Other Studies

1 other study(ies) available for thymopentin and HIV Coinfection

ArticleYear
[Late effect of thymopentin in HIV infection].
    Medicina, 1993, Volume: 53, Issue:3

    Topics: CD4-Positive T-Lymphocytes; Female; Follow-Up Studies; HIV Infections; Humans; Male; Thymopentin

1993